Epoch 39: Biotech Headwinds Swirl
Follow-on’s, IPOs, Private Financings, M&A
Welcome to the 33 NEW Biotech Innovators who have joined us this month! If you haven’t subscribed, join the 1,316 researchers, investors, operators, academics, clinicians and entrepreneurs by subscribing here:
Hello Avatar! Welcome to another week of biotech analysis. Today’s commentary is as always on Thursday focused on the general market update. For…
Keep reading with a 7-day free trial
Subscribe to BowTiedBiotech to keep reading this post and get 7 days of free access to the full post archives.